NCT01655225 2022-04-08A Study of LY3023414 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed156 enrolled
NCT01026415 2014-12-18Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)Seagen Inc.Phase 1 Completed73 enrolled